A Complex Presentation: Psychosis in a Patient Diagnosed With Lennox-Gastaut Syndrome

被引:0
作者
Singh, Gurraj [1 ]
Gill, Gurtej [2 ]
Singh, Satwant [3 ]
Roshan, Nikhita S. [4 ]
Lalendran, Akshita [5 ]
Gunturu, Sasidhar [2 ]
机构
[1] Bergen New Bridge Med Ctr, Psychiat, Paramus, NJ 07652 USA
[2] BronxCare Hlth Syst, Psychiat, New York, NY USA
[3] Interfaith Med Ctr, Psychiat & Behav Sci, Brooklyn, NY USA
[4] Father Muller Med Coll, Neurol, Mangalore, India
[5] BronxMedcare Hosp, Psychiat & Behav Sci, New York, NY USA
关键词
breakthrough seizure; seizure activity; psychosis; childhood epilepsy; lennox-gastaut syndrome; DE-NOVO MUTATIONS; CACNA1A; EPILEPSY;
D O I
10.7759/cureus.65010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Lennox-Gastaut syndrome (LGS) is a form of severe childhood epilepsy, with most children experiencing seizures before reaching the age of eight. Typically, patients have multiple types of seizures, making an accurate diagnosis challenging. While it can be secondary to other causes, often, it is idiopathic. Over time, children develop cognitive impairment, leading to intellectual disability. The mainstay of treatment and management is seizure control. However, management remains challenging due to the complexity of the syndrome, as it is associated with multiple seizure types, intellectual deterioration, and other psychiatric comorbidities. We present the case of a 19-year-old male diagnosed with LGS and treated with various available therapies, who demonstrated multiple breakthrough seizures, significant neurocognitive disabilities, and behavior challenges. Additionally, the patient displayed psychotic features of auditory hallucinations, aggression, and attempts at self-mutilation, a rare clinical presentation in LGS.
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Management of Lennox-Gastaut syndrome with rufinamide
    Kirmani, Batool F.
    Mungall, Diana
    Aceves, Jose
    JOURNAL OF PEDIATRIC EPILEPSY, 2013, 2 (02) : 109 - 113
  • [32] ELECTROCLINICAL SEIZURES IN LENNOX-GASTAUT SYNDROME
    YAQUB, BA
    EPILEPSIA, 1993, 34 (01) : 120 - 127
  • [33] Lennox-Gastaut Syndrome: a Current Review
    Prelack M.S.
    DiGiovine M.P.
    Current Pediatrics Reports, 2017, 5 (1) : 13 - 16
  • [34] Clobazam in the treatment of Lennox-Gastaut syndrome
    Conry, Joan A.
    Ng, Yu-Tze
    Paolicchi, Juliann M.
    Kernitsky, Lydia
    Mitchell, Wendy G.
    Ritter, Frank J.
    Collins, Stephen D.
    Tracy, Katherine
    Kormany, William N.
    Abdulnabi, Radhi
    Riley, Bill
    Stolle, Julie
    EPILEPSIA, 2009, 50 (05) : 1158 - 1166
  • [35] Lennox-Gastaut syndrome in Spain: a descriptive retrospective epidemiological study
    Luis Herranz, Jose
    Casas-Fernandez, Carlos
    Campistol, Jaume
    Campos-Castello, Jaime
    Rufo-Campos, Miguel
    Torres-Falcon, Alberto
    de Rosendo, Jesus
    REVISTA DE NEUROLOGIA, 2010, 50 (12) : 711 - 717
  • [36] Anti-seizure medications for Lennox-Gastaut syndrome
    Brigo, Francesco
    Jones, Katherine
    Eltze, Christin
    Matricardi, Sara
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (04):
  • [37] CHD2 mutations in Lennox-Gastaut syndrome
    Lund, Caroline
    Brodtkorb, Eylert
    Oye, Ane-Marte
    Rosby, Oddveig
    Selmer, Kaja Kristine
    EPILEPSY & BEHAVIOR, 2014, 33 : 18 - 21
  • [38] Patient and Caregiver Health State Utilities in Lennox-Gastaut Syndrome and Dravet Syndrome
    Lo, Siu Hing
    Lloyd, Andrew
    Marshall, Jade
    Vyas, Kishan
    CLINICAL THERAPEUTICS, 2021, 43 (11) : 1861 - +
  • [39] Prevalence and descriptive epidemiology of Lennox-Gastaut syndrome among Atlanta children
    Trevathan, E
    Murphy, CC
    YearginAllsopp, M
    EPILEPSIA, 1997, 38 (12) : 1283 - 1288
  • [40] Update on the management of Lennox-Gastaut syndrome with a focus on rufinamide
    Stafstrom, Carl E.
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2009, 5 : 547 - 551